German scientists have identified a gene that has higher levels in colon cancer patients whose tumors are destined to spread. By initiating a signaling pathway in the cancer cell, MACC1 (Metastasis-Associated in Colon Cancer 1) promotes faster cell growth and cancer spread to distant sites in the body (metastasis) .
Their research was published online in Nature Medicine.
About a third of patients whose cancer is found in early stages will eventually have it spread to other organs. Measuring MACC1 may help doctors identify those patients, treat them more aggressively, and follow them more closely.
Cancer researchers at the Max Delbrück Center for Molecular Medicine in Berlin studied tumor tissue from 103 patients with colorectal cancer. Sixty of those patients didn’t have any sign of cancer spread when they were diagnosed. Of the 60, 37 were alive and cancer-free five years later. They had low levels of MACC1 in their tumors.
On the other hand, 23 patients had cancer spread. They had higher tumor levels of MACC1.
Ulrike Stein and his colleagues concluded,
For clinical practice, MACC1 will be useful for the identification of poor prognosis subjects with colorectal cancer and is a promising new target for intervention in metastasis formation.
SOURCE: Stein et al., Nature Medicine, Advance Access December 21, 2008.
Leave a Reply
Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. FightCRC is not responsible for the medical accuracy of any comments left by persons other than FightCRC staff members. FightCRC staff members monitor comments and may respond publicly where appropriate.
Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.
We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).